Editor: Atta-ur-Rahman

Frontiers in Clinical Drug Research-Anti Infectives

Volume 2

eBook: US $39 Special Offer (PDF + Printed Copy): US $138
Printed Copy: US $119
Library License: US $156
ISSN: 2452-3208 (Print)
ISSN: 2352-3212 (Online)
ISBN: 978-1-68108-154-0 (Print)
ISBN: 978-1-68108-153-3 (Online)
Year of Publication: 2016
DOI: 10.2174/97816810815331160201


Frontiers in Clinical Drug Research – Anti Infectives is an eBook series that brings updated reviews to readers interested in learning about advances in the development of pharmaceutical agents for the treatment of infectious diseases. The scope of the eBook series covers a range of topics including the chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs employed in the treatment of infectious diseases. Reviews in this series also include research on multi drug resistance and pre-clinical / clinical findings on novel antibiotics, vaccines, antifungal agents and antitubercular agents. Frontiers in Clinical Drug Research – Anti infectives is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of anti-infective drug discovery and epidemiology.

The second volume of this series features reviews that cover a variety of topics including:

  • - Identification of nosocomial pathogens and antimicrobials using phenotypic techniques
  • - Topical antimicrobials
  • - Anti-infective drug safety
  • - Antimicrobial resistance
  • - and much more.


The second volume of Frontiers in Clinical Drug Research – Anti Infectives comprises seven chapters in various important fields including utilization of analytical techniques for identifying the nosocomial pathogens and antimicrobials, topical antimicrobials, anti-infective drug safety at global level, antimicrobial resistance and others.

In the first chapter, García-Contreras and colleagues discuss the current advancement in novel bacterial anti-infective drug development. They also discuss the in vitro and in vivo activity of anti-infective agents by analyzing their mechanisms of action and other recent advances in this field.

In the second chapter, Totapally and Raszynski have discussed the threat of antibiotic resistance at the global level, the causes involved in the development of antibiotic resistance and some solutions to overcome this huge problem.

Castro-Pastrana et al., in the third chapter discuss certain aspects of chemoinformatics, predictive clinical pharmacology and systems biology. They also discuss the utilization of preclinical models, in silico methods, translational biomarkers, genomics and the strategies of postmarketing surveillance during the development of anti-infective drugs for safety evaluation and risk management.

In chapter 4, Paulson discusses the topical antimicrobial products and describes their classification, mechanism of action, indications and the information regarding the products available in the market. Horka and colleagues mainly focus on nosocomial infections in chapter 5 and the analytical techniques helpful in the identification and estimation of levels of antibiotics and microorganisms in real samples.

In chapter 6, Fernández and Camacho present an overview of the use of natural product extracts, compounds and fractions that are known for their antimalarial activity. They also highlighted the strategies and challenges linked with contemporary antimalarial natural drug research, in the light of recent literature. In the last chapter, Teixera et al. discuss the antimicrobial agents that can be used for therapy in vaginal infections, different dosage forms and the risks and benefit associated with them. They also explain the new strategies and approaches applied in the vaginal drug delivery.

I would like to thanks all the authors for their excellent contributions. I am grateful to the outstanding efforts of the team of Bentham Science Publishers, comprising Dr. Faryal Sami and Mr. Shehzad Naqvi led by Mr. Mahmood Alam, Director Bentham Science Publishers.

Prof. Atta-ur-Rahman, FRS
Kings College
University of Cambridge


.COVID 19 – Monitoring with IoT Devices.
.Recent Advances in the Application of Marine Natural Products as Antimicrobial Agents.
.Recent Trends and The Future of Antimicrobial Agents - Part 2.
.COVID-19: Origin, Impact and Management (Part 1).